P20036 (DPA1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 118.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: HLA class II histocompatibility antigen, DP alpha 1 chain Alternative name(s): DP(W3) DP(W4) HLA-SB alpha chain MHC class II DP3-alpha MHC class II DPA1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 260 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. |
| Subunit structure | Heterodimer of an alpha and a beta subunit; also referred as MHC class II molecule. In the endoplasmic reticulum (ER) it forms a heterononamer; 3 MHC class II molecules bind to a CD74 homotrimer (also known as invariant chain or HLA class II histocompatibility antigen gamma chain). In the endosomal/lysosomal system; CD74 undergoes sequential degradation by various proteases; leaving a small fragment termed CLIP on each MHC class II molecule. MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells, in order to release CLIP and facilitate the binding of antigenic peptides. |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus › trans-Golgi network membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note: The MHC class II complex transits through a number of intracellular compartments in the endocytic pathway until it reaches the cell membrane for antigen presentation. |
| Polymorphism | The following alleles of DPA1 are known: DPA1*01:03, DPA1*01:04, DPA1*01:05, DPA1*01:06, DPA1*01:07, DPA1*01:08, DPA1*01:09, DPA1*01:10, DPA1*02:01, DPA1*02:02, DPA1*02:03, DPA1*02:04, DPA1*03:01, DPA1*03:02, DPA1*03:03, DPA1*04:01 The sequence shown is that of DPA1*01:03. |
| Sequence similarities | Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. |
| Sequence caution | The sequence AAC64233.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence AAD42927.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 28 | 28 | |||||||||||||||||||||||||||||||||
| Chain | 29 – 260 | 232 | HLA class II histocompatibility antigen, DP alpha 1 chain | PRO_0000018967 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Topological domain | 29 – 222 | 194 | Extracellular Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 223 – 245 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 246 – 260 | 15 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
| Domain | 118 – 210 | 93 | Ig-like C1-type | ||||||||||||||||||||||||||||||||
| Region | 29 – 115 | 87 | Alpha-1 | ||||||||||||||||||||||||||||||||
| Region | 116 – 209 | 94 | Alpha-2 | ||||||||||||||||||||||||||||||||
| Region | 210 – 222 | 13 | Connecting peptide | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Glycosylation | 109 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||
| Glycosylation | 149 | 1 | N-linked (GlcNAc...) Ref.29 | ||||||||||||||||||||||||||||||||
| Disulfide bond | 138 ↔ 194 | By similarity | |||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Natural variant | 42 | 1 | A → M in allele DPA1*02:02, allele DPA1*02:04, allele DPA1*03:01, allele DPA1*03:02 and allele DPA1*03:03; requires 2 nucleotide substitutions. | VAR_058832 | |||||||||||||||||||||||||||||||
| Natural variant | 42 | 1 | A → T. Corresponds to variant rs1126533 [ dbSNP | Ensembl ]. | VAR_047683 | |||||||||||||||||||||||||||||||
| Natural variant | 42 | 1 | A → V. Corresponds to variant rs1126534 [ dbSNP | Ensembl ]. | VAR_047684 | |||||||||||||||||||||||||||||||
| Natural variant | 49 | 1 | P → T in allele DPA1*04:01. Corresponds to variant rs2308907 [ dbSNP | Ensembl ]. | VAR_058833 | |||||||||||||||||||||||||||||||
| Natural variant | 54 | 1 | M → T in allele DPA1*01:09. Corresponds to variant rs1042175 [ dbSNP | Ensembl ]. | VAR_058834 | |||||||||||||||||||||||||||||||
| Natural variant | 59 | 1 | E → D in allele DPA1*01:04, allele DPA1*01:08, allele DPA1*03:03 and allele DPA1*04:01. Corresponds to variant rs2308910 [ dbSNP | Ensembl ]. | VAR_058835 | |||||||||||||||||||||||||||||||
| Natural variant | 62 | 1 | M → K. Corresponds to variant rs2308912 [ dbSNP | Ensembl ]. | VAR_058836 | |||||||||||||||||||||||||||||||
| Natural variant | 62 | 1 | M → L. Corresponds to variant rs2308911 [ dbSNP | Ensembl ]. | VAR_047685 | |||||||||||||||||||||||||||||||
| Natural variant | 62 | 1 | M → Q in allele DPA1*01:06, allele DPA1*02:01, allele DPA1*02:02 and allele DPA1*02:04; requires 2 nucleotide substitutions. Corresponds to variant rs36013091 [ dbSNP | Ensembl ]. | VAR_058850 | |||||||||||||||||||||||||||||||
| Natural variant | 74 | 1 | W → C in allele DPA1*01:10. Corresponds to variant rs72558171 [ dbSNP | Ensembl ]. | VAR_058837 | |||||||||||||||||||||||||||||||
| Natural variant | 81 | 1 | Q → R in allele DPA1*01:08, allele DPA1*02:01, allele DPA1*02:02, allele DPA1*02:03, allele DPA1*02:04 and allele DPA1*04:01. Corresponds to variant rs1042178 [ dbSNP | Ensembl ]. | VAR_047686 | |||||||||||||||||||||||||||||||
| Natural variant | 82 | 1 | A → T in allele DPA1*01:07. Corresponds to variant rs41543112 [ dbSNP | Ensembl ]. | VAR_058838 | |||||||||||||||||||||||||||||||
| Natural variant | 97 | 1 | L → S in allele DPA1*03:01 and allele DPA1*03:03. Corresponds to variant rs2308917 [ dbSNP | Ensembl ]. | VAR_047687 | |||||||||||||||||||||||||||||||
| Natural variant | 100 | 1 | N → D in allele DPA1*02:04. Corresponds to variant rs61759929 [ dbSNP | Ensembl ]. | VAR_058839 | |||||||||||||||||||||||||||||||
| Natural variant | 103 | 1 | T → I in allele DPA1*04:01. Corresponds to variant rs41559316 [ dbSNP | Ensembl ]. | VAR_058840 | |||||||||||||||||||||||||||||||
| Natural variant | 104 | 1 | L → A in allele DPA1*04:01; requires 2 nucleotide substitutions. | VAR_058841 | |||||||||||||||||||||||||||||||
| Natural variant | 114 | 1 | T → A in allele DPA1*01:05, allele DPA1*02:01, allele DPA1*02:02, allele DPA1*02:03, allele DPA1*02:04 and allele DPA1*04:01. Corresponds to variant rs1126542 [ dbSNP | Ensembl ]. | VAR_047688 | |||||||||||||||||||||||||||||||
| Natural variant | 127 | 1 | P → A in allele DPA1*04:01. Corresponds to variant rs41562016 [ dbSNP | Ensembl ]. | VAR_058842 | |||||||||||||||||||||||||||||||
| Natural variant | 142 | 1 | K → R in allele DPA1*02:01 and allele DPA1*02:02. Corresponds to variant rs1042190 [ dbSNP | Ensembl ]. | VAR_047689 | |||||||||||||||||||||||||||||||
| Natural variant | 158 | 1 | L → P in allele DPA1*02:01, allele DPA1*02:02 and allele DPA1*04:01. Corresponds to variant rs2308930 [ dbSNP | Ensembl ]. | VAR_058843 | |||||||||||||||||||||||||||||||
| Natural variant | 191 | 1 | F → V in allele DPA1*02:01, allele DPA1*02:02 and allele DPA1*04:01. Corresponds to variant rs1042308 [ dbSNP | Ensembl ]. | VAR_047690 | |||||||||||||||||||||||||||||||
| Natural variant | 221 | 1 | T → A in allele DPA1*04:01. | VAR_058844 | |||||||||||||||||||||||||||||||
| Natural variant | 259 | 1 | T → P in allele DPA1*02:01, allele DPA1*02:02 and allele DPA1*04:01. Corresponds to variant rs1126769 [ dbSNP | Ensembl ]. | VAR_058845 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 237 | 1 | I → F in CAA25143. Ref.7 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 35 – 49 | 15 | |||||||||||||||||||||||||||||||||
| Beta strand | 51 – 57 | 7 | |||||||||||||||||||||||||||||||||
| Beta strand | 60 – 66 | 7 | |||||||||||||||||||||||||||||||||
| Turn | 67 – 70 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 71 – 76 | 6 | |||||||||||||||||||||||||||||||||
| Helix | 77 – 80 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 87 – 106 | 20 | |||||||||||||||||||||||||||||||||
| Turn | 107 – 110 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 119 – 126 | 8 | |||||||||||||||||||||||||||||||||
| Beta strand | 134 – 145 | 12 | |||||||||||||||||||||||||||||||||
| Beta strand | 149 – 154 | 6 | |||||||||||||||||||||||||||||||||
| Beta strand | 163 – 165 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 176 – 184 | 9 | |||||||||||||||||||||||||||||||||
| Beta strand | 192 – 197 | 6 | |||||||||||||||||||||||||||||||||
| Beta strand | 205 – 209 | 5 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The genomic organisation and nucleotide sequence of the HLA-SB(DP) alpha gene." Lawrance S.K., Das H.K., Pan J., Weissman S.M. Nucleic Acids Res. 13:7515-7528(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DPA1*01:03). |
| [2] | "Class II genes of the human major histocompatibility complex. Evolution of the DP region as deduced from nucleotide sequences of the four genes." Gustafsson K., Widmark E., Jonsson A.-K., Servenius B., Sachs D.H., Larhammar D., Rask L., Peterson P.A. J. Biol. Chem. 262:8778-8786(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DPA1*01:03). |
| [3] | "Epitope recognition by a DP alpha chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DP alpha chain and its polymorphic DP beta chain partner." Young J.A., Lindsay J., Bodmer J.G., Trowsdale J. Hum. Immunol. 23:37-44(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DPA1*01:03). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Thymus. |
| [5] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DPA1*01:03). |
| [6] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes." Auffray C., Lillie J.W., Arnot D., Grossberger D., Kappes D., Strominger J.L. Nature 308:327-333(1984) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 28-260 (ALLELE DPA1*01:03). |
| [8] | "A novel DPA1 allele (DPA1*0203) composed of known epitopes." Muntau B., Thye T., Pirmez C., Horstmann R.D. Tissue Antigens 49:668-669(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 32-115 (ALLELE DPA1*02:03). |
| [9] | "Three new DP alleles identified in sub-Saharan Africa: DPB1*7401, DPA1*02013, and DPA1*0302." Steiner L.L., Cavalli A., Zimmerman P.A., Boatin B.A., Titanji V.P., Bradley J.E., Lucius R., Nutman T.B., Begovich A.B. Tissue Antigens 51:653-657(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 34-115 (ALLELE DPA1*03:02). |
| [10] | "Sequencing-based typing reveals new insight in HLA-DPA1 polymorphism." Rozemuller E.H., Bouwens A.G., van Oort E., Versluis L.F., Marsh S.G., Bodmer J.G., Tilanus M.G. Tissue Antigens 45:57-62(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-116 AND 211-260 (ALLELE DPA1*01:04), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-229 (ALLELE DPA1*02:01), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-116 AND 211-260 (ALLELE DPA1*02:02), NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-115 AND 211-260 (ALLELES DPA1*03:01 AND DPA1*401). |
| [11] | "A new HLA-DPA1 allele, DPA1*02016, identified in African-American population." McDaniel D.O., Nguyen C., McDaniel L.S. Tissue Antigens 56:197-198(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-117 (ALLELE DPA1*02:01). |
| [12] | "High-resolution sequence-based DPA1 typing identified two novel DPA1 alleles, DPA1*010303 and DPA1*0303, from a Kenyan population." Luo M., Bamforth J., Gill K., Cohen C., Brunham R.C., Plummer F.A. Tissue Antigens 65:120-122(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*03:03). |
| [13] | "Identification of a novel DPA1 allele, DPA1*010602, in an East African population." Peterson T.A., Luo M., Mao X., Brunham R.C., Plummer F.A. Hum. Immunol. 69:885-886(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*01:06). |
| [14] | "Description of two novel HLA-DPA1 alleles: DPA1*0110 and DPA1*010304." Lee K.W. Tissue Antigens 71:575-577(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELES DPA1*01:03 AND DPA1*01:10). |
| [15] | "A novel HLA-DPA1*0204 allele was identified in a Chinese individual." Zhao H., Dai W.-J., He Y.-M., Zhu F.-M., Yan L.-X. Tissue Antigens 71:577-578(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*02:04). |
| [16] | Steiner L., Begovich A., Suraj V. Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*01:06). |
| [17] | "One new DPA1 Allele." Grams S.E., Begovich A., Mangaccat J. Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*01:08). |
| [18] | "Novel human HLA-DPA1 allele identified in potential bone marrow donors." Bassinger S., Wu J., Williams T.M. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-115 (ALLELE DPA1*01:09). |
| [19] | "DPA1 polymorphism in Polynesians." Varney M.D., Gavrilidis A., Abbott W. Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 36-115 (ALLELE DPA1*01:07). |
| [20] | "DPA1*0105, a novel DPA1 variant in a negrois population." May J., Krestchmer C., Schnittger L., Striecker R., Kremoner P.G., Meyer C.G. Tissue Antigens 48:593-594(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-115 (ALLELE DPA1*01:05). |
| [21] | "Exon 2, 3, and 4 polymorphism of HLA-DPA1." Rozemuller E.H., Versluis L.F., Bouwens A.G., Tilanus M.G. Immunogenetics 41:53-53(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 117-210 (ALLELES DPA1*01:04; DPA1*02:02; DPA1*03:01 AND DPA1*04:01). |
| [22] | "Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes." Trowsdale J., Lee J., Carey J., Grosveld F., Bodmer J., Bodmer W. Proc. Natl. Acad. Sci. U.S.A. 80:1972-1976(1983) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 178-209 (ALLELE DPA1*01:03). |
| [23] | "Invariant chain structure and MHC class II function." Cresswell P. Cell 84:505-507(1996) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [24] | "Presentation of antigens by MHC class II molecules: getting the most out of them." Villadangos J.A. Mol. Immunol. 38:329-346(2001) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [25] | "MHC class II molecules on the move for successful antigen presentation." Rocha N., Neefjes J. EMBO J. 27:1-5(2008) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [26] | "Autophagy in MHC class II presentation: sampling from within." Menendez-Benito V., Neefjes J. Immunity 26:1-3(2007) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [27] | "MHC class II transport at a glance." Berger A.C., Roche P.A. J. Cell Sci. 122:1-4(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [28] | "CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract." Beswick E.J., Reyes V.E. World J. Gastroenterol. 15:2855-2861(2009) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [29] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-149, MASS SPECTROMETRY. Tissue: Liver. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X03100 Genomic DNA. Translation: CAA26887.1. M27487 mRNA. Translation: AAA63220.1. AK292709 mRNA. Translation: BAF85398.1. AL645931 Genomic DNA. No translation available. AL805913 Genomic DNA. Translation: CAI18549.1. BX120009, BX005422 Genomic DNA. Translation: CAM25981.1. BX005422, BX120009 Genomic DNA. Translation: CAM26119.1. CR759829, CR762479 Genomic DNA. Translation: CAQ07261.1. CR759795 Genomic DNA. Translation: CAQ07433.1. CR847849 Genomic DNA. Translation: CAQ07485.1. CR759904 Genomic DNA. Translation: CAQ09865.1. CR762479, CR759829 Genomic DNA. Translation: CAQ10344.1. CH471081 Genomic DNA. Translation: EAX03669.1. X00457 mRNA. Translation: CAA25143.1. Z48473 Genomic DNA. No translation available. AF013767 Genomic DNA. Translation: AAC64233.1. Sequence problems. X78199 Genomic DNA. No translation available. X82393 Genomic DNA. No translation available. X82394 Genomic DNA. No translation available. X78198 Genomic DNA. No translation available. X82391 Genomic DNA. No translation available. X79475 Genomic DNA. No translation available. X79477 Genomic DNA. No translation available. X79479 Genomic DNA. No translation available. X79481 Genomic DNA. No translation available. AF165160 Genomic DNA. Translation: AAD47826.1. AY618553 Genomic DNA. Translation: AAT92097.1. EU729350 Genomic DNA. Translation: ACH88749.1. DQ274060 Genomic DNA. Translation: ABB88406.1. DQ274061 Genomic DNA. Translation: ABB88407.1. EU304462 Genomic DNA. Translation: ABY27081.1. U87556 Genomic DNA. Translation: AAB97110.1. AF346471 Genomic DNA. Translation: AAK27152.1. AY650051 Genomic DNA. Translation: AAT67468.1. AF076284 Genomic DNA. Translation: AAD42927.1. Sequence problems. X96984 Genomic DNA. No translation available. X80482 Genomic DNA. No translation available. X81347 Genomic DNA. No translation available. X81348 Genomic DNA. No translation available. K00514 Genomic DNA. Translation: AAA59786.1. | ||||||||||||
| IPI | IPI00021711. | ||||||||||||
| PIR | HLHUSB. A29313. | ||||||||||||
| RefSeq | NP_001229453.1. NM_001242524.1. NP_001229454.1. NM_001242525.1. NP_291032.2. NM_033554.3. | ||||||||||||
| UniGene | Hs.347270. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P20036. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | P20036. 4 interactions. | ||||||||||||
| MINT | MINT-1488672. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P20036. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 122204. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P20036. | ||||||||||||
| PRIDE | P20036. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 3113. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000374808; ENSP00000363941; ENSG00000168384. ENST00000383224; ENSP00000372711; ENSG00000206291. ENST00000415247; ENSP00000405838; ENSG00000224103. ENST00000419277; ENSP00000393566; ENSG00000231389. ENST00000422504; ENSP00000406250; ENSG00000228163. ENST00000428995; ENSP00000402872; ENSG00000231389. ENST00000443117; ENSP00000397587; ENSG00000235844. ENST00000454805; ENSP00000397139; ENSG00000229685. ENST00000515317; ENSP00000427429; ENSG00000236177. ENST00000549300; ENSP00000449627; ENSG00000229685. ENST00000550456; ENSP00000446736; ENSG00000236177. ENST00000550806; ENSP00000449242; ENSG00000228163. ENST00000551196; ENSP00000448034; ENSG00000235844. ENST00000551933; ENSP00000448097; ENSG00000206291. ENST00000552158; ENSP00000447713; ENSG00000168384. | ||||||||||||
| GeneID | 3113. | ||||||||||||
| KEGG | hsa:3113. | ||||||||||||
| UCSC | uc003ocs.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 3113. | ||||||||||||
| GeneCards | GC06M033032. | ||||||||||||
| HGNC | HGNC:4938. HLA-DPA1. | ||||||||||||
| HPA | HPA017967. | ||||||||||||
| MIM | 142880. gene. | ||||||||||||
| neXtProt | NX_P20036. | ||||||||||||
| PharmGKB | PA35062. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG235591. | ||||||||||||
| HOVERGEN | HBG006862. | ||||||||||||
| InParanoid | P20036. | ||||||||||||
| KO | K06752. | ||||||||||||
| OMA | LNVTWLC. | ||||||||||||
| OrthoDB | EOG45X7XB. | ||||||||||||
| PhylomeDB | P20036. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P20036. | ||||||||||||
| Bgee | P20036. | ||||||||||||
| CleanEx | HS_HLA-DPA1. | ||||||||||||
| Genevestigator | P20036. | ||||||||||||
| GermOnline | ENSG00000168384. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 1 hit. 3.10.320.10. 1 hit. | ||||||||||||
| InterPro | IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003006. Ig/MHC_CS. IPR003597. Ig_C1-set. IPR011162. MHC_I/II-like_Ag-recog. IPR014745. MHC_II_a/b_N. IPR001003. MHC_II_a_N. [Graphical view] | ||||||||||||
| Pfam | PF07654. C1-set. 1 hit. PF00993. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00407. IGc1. 1 hit. SM00920. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF54452. MHC_I/II-like_Ag-recog. 1 hit. | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. PS00290. IG_MHC. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | HLA-DPA1. human. | ||||||||||||
| EvolutionaryTrace | P20036. | ||||||||||||
| GenomeRNAi | 3113. | ||||||||||||
| NextBio | 12353. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | DPA1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P20036 Secondary accession number(s): A9YWH7 Q9XS10 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
